1. Home
  2. PIK3CA-Related Overgrowth Spectrum Doctors Near Me
  3. Latest Advances

PIK3CA-Related Overgrowth Spectrum Latest Advances

Find the Latest Research About PIK3CA-Related Overgrowth Spectrum

Find a DoctorCondition OverviewLatest AdvancesClinical TrialsTreatments

Filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 11/08/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9364 publications

Lung Cancer Spectrum, Molecular Alterations and PD-L1 Expression.

Lung Cancer Spectrum, Molecular Alterations and PD-L1 Expression.

Journal: Irish medical journal
Published: October 27, 2026

Molecular profiling of ovarian cancer is feasible and provides valuable therapeutic and research information to women in Aotearoa New Zealand.

Molecular profiling of ovarian cancer is feasible and provides valuable therapeutic and research information to women in Aotearoa New Zealand.

Journal: The New Zealand medical journal
Published: October 23, 2026

From Variant Detection to Clinical Actionability: Expanding the Clinical Perspective on Targeted NGS Profiling in Breast Cancer.

From Variant Detection to Clinical Actionability: Expanding the Clinical Perspective on Targeted NGS Profiling in Breast Cancer.

Journal: Cancer control : journal of the Moffitt Cancer Center
Published: October 22, 2026

Plexiform fibromyxoma of the stomach with PIK3CA mutation: a case report.

Plexiform fibromyxoma of the stomach with PIK3CA mutation: a case report.

Journal: Hong Kong medical journal = Xianggang yi xue za zhi
Published: October 20, 2026

Impact of Phosphatidylinositol 3-Kinase and B-Raf Mutations in Rat Sarcoma Wild-Type Metastatic Colorectal Cancer.

Impact of Phosphatidylinositol 3-Kinase and B-Raf Mutations in Rat Sarcoma Wild-Type Metastatic Colorectal Cancer.

Journal: Journal of visualized experiments : JoVE
Published: October 17, 2026

Gedatolisib after CDK4/6 inhibition in HR-Positive/HER2-negative advanced breast cancer: pharmacology, phase iii evidence, and therapeutic positioning.

Gedatolisib after CDK4/6 inhibition in HR-Positive/HER2-negative advanced breast cancer: pharmacology, phase iii evidence, and therapeutic positioning.

Journal: Expert opinion on pharmacotherapy
Published: October 17, 2026

PIK3CA Mutations in Advanced or Recurrent Endometrial Cancer: An Exploratory Molecular Profiling From the Phase II MITO END-3 Study.

PIK3CA Mutations in Advanced or Recurrent Endometrial Cancer: An Exploratory Molecular Profiling From the Phase II MITO END-3 Study.

Journal: JCO precision oncology
Published: October 16, 2026

PI3K signaling in breast cancer: therapeutic advances versus adaptive resistance.

PI3K signaling in breast cancer: therapeutic advances versus adaptive resistance.

Journal: The Journal of clinical investigation
Published: October 15, 2026

Zovegalisib for PIK3CA-driven vascular and lymphatic malformations: a drug evaluation.

Zovegalisib for PIK3CA-driven vascular and lymphatic malformations: a drug evaluation.

Journal: Expert opinion on investigational drugs
Published: October 14, 2026

Erratum: Clinicogenomic Landscape and Function of PIK3CA, AKT1, and PTEN Mutations in Breast Cancer.

Erratum: Clinicogenomic Landscape and Function of PIK3CA, AKT1, and PTEN Mutations in Breast Cancer.

Journal: JCO precision oncology
Published: October 13, 2026

Genomic Landscape and Clinical Actionability of Skin Adnexal Carcinomas.

Genomic Landscape and Clinical Actionability of Skin Adnexal Carcinomas.

Journal: JCO precision oncology
Published: October 13, 2026

Malignant phyllodes tumor of the breast with distant metastasis: a clinicopathological and molecular genetic analysis of ten cases

Malignant phyllodes tumor of the breast with distant metastasis: a clinicopathological and molecular genetic analysis of ten cases

Journal: Zhonghua bing li xue za zhi = Chinese journal of pathology
Published: October 09, 2026
Showing 1-12 of 9,364

Last Updated: 11/08/2026

For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved